Cargando…

MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma

DNA replication is a central procedure of cell proliferation, whereas aberrant DNA replication is indicated to be a driving force of oncogenesis. Minichromosome maintenance complex component 7 (MCM7) plays an essential role in initiating DNA replication. To investigate the potential oncogenic proper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Kai, Wang, Zhixin, Fan, Haining, Li, Juan, Liu, Jie, Li, Pingping, Liang, Zheyong, An, Hongli, Jiang, Yina, Lin, Qiushi, Dong, Xiaoqun, Liu, Peijun, Liu, Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386449/ https://www.ncbi.nlm.nih.gov/pubmed/28182015 http://dx.doi.org/10.1038/cddis.2016.352

Ejemplares similares

Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
por: Qu, Kai, et al.
Publicado: (2022)

Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells
por: Liang, Zheyong, et al.
Publicado: (2017)

Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth
por: Li, Juan, et al.
Publicado: (2017)

Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2021)

Bioinformatics Analysis Reveals MCM3 as an Important Prognostic Marker in Cervical Cancer
por: Ma, Hui, et al.
Publicado: (2021)

Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma
por: Li, Hong-Tao, et al.
Publicado: (2020)

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence
por: Liu, Mingyu, et al.
Publicado: (2018)

MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions(,)
por: Choy, Bonnie, et al.
Publicado: (2016)

MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder
por: Liu, Ziru, et al.
Publicado: (2016)

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
por: Zhou, Huifang, et al.
Publicado: (2019)

Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas
por: Hua, Cong, et al.
Publicado: (2014)

Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Li, Pingping, et al.
Publicado: (2020)

Correction to: Minichromosome Maintenance (MCM) family as potential diagnostic and prognostic tumor markers for human gliomas
por: Hua, Cong, et al.
Publicado: (2019)

Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo
por: Zhou, Lei, et al.
Publicado: (2016)

Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
por: Liu, Jie, et al.
Publicado: (2017)

Overexpression of non-SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma
por: Liu, Wanwei, et al.
Publicado: (2017)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Zhuang, Liping, et al.
Publicado: (2015)

Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer
por: Go, Se-Il, et al.
Publicado: (2022)

A unique DNA entry gate serves for regulated loading of the eukaryotic replicative helicase MCM2–7 onto DNA
por: Samel, Stefan A., et al.
Publicado: (2014)

MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target
por: Wang, Yifei, et al.
Publicado: (2022)

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients
por: Bahnassy, Abeer A, et al.
Publicado: (2004)

Conditional transcriptional relationships may serve as cancer prognostic markers
por: Yu, Hui, et al.
Publicado: (2021)

Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma
por: Mo, Zhijing, et al.
Publicado: (2016)

CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells
por: Mao, Xiaona, et al.
Publicado: (2017)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer
por: Song, Shaoran, et al.
Publicado: (2022)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer
por: Liu, Donghui, et al.
Publicado: (2023)

O-GlcNAc transferase associates with the MCM2–7 complex and its silencing destabilizes MCM–MCM interactions
por: Leturcq, Maïté, et al.
Publicado: (2018)

Functional aspects of primary cilium in signaling, assembly and microenvironment in cancer
por: Wang, Bo, et al.
Publicado: (2020)

Elevated CRB3 expression suppresses breast cancer stemness by inhibiting β‐catenin signalling to restore tamoxifen sensitivity
por: Li, Pingping, et al.
Publicado: (2018)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2017)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

Analysis of MCM Proteins’ Role as a Potential Target of Statins in Patients with Acute Type A Aortic Dissection through Bioinformatics
por: Liang, Zheyong, et al.
Publicado: (2021)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

CD148 Serves as a Prognostic Marker of Gastric Cancer and Hinders Tumor Progression by Dephosphorylating EGFR
por: Sun, Yiting, et al.
Publicado: (2020)

Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker
por: Lui, Ka Yin, et al.
Publicado: (2017)

DNA methylation of Hugl‐2 is a prognostic biomarker in kidney renal clear cell carcinoma
por: Miao, Yi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ujlfdeh48h9h6njspna04dmo9